最新新聞
- 反詐騙宣導
- 安肽生醫與奈捷生技合力發展抗體epitope binning獲得重大成果(2021/7/12)
- COVID-19 ANTIGEN RAPID TEST donation(2021/05/24)
|
|
|
Dec. 24. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED PROVISIONAL AUTHORIZATION FROM SINGAPORE HEALTH SCIENCES AUTHORITY (HSA) Vstrip COVID-19 Antigen Rapid Test acquired provisional authorization from Singapore Health Sciences Authority (HSA). |
 |
|
Dec. 02. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST OBTAINS CE MARKING PANION & BF BIOTECH INC. XIZHI FACTORY is notified by Obelis s.a. on 2020/12/01 that Vstrip COVID-19 Antigen Rapid Test is in compliance with European Council Directive 98/97/EC – article 10 requirements. |
 |
|
Sep .25. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST IS VALIDATED AND FOUND TO BE SATISFACTORY BY INDIA COUNCIL OF MEDICAL RESEARCH (ICMR). Vstrip COVID-19 Antigen Rapid Test is validated and found to be satisfactory by India Council of Medical Research (ICMR). |
 |
|
Aug .27. 2020- VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED APPROVAL FROM TAIWAN MINISTRY OF HEALTH AND WELFARE Vstrip COVID-19 Antigen Rapid Test is approved by Taiwan Ministry of Health and Welfare in response to emergency public health circumstances. Approval Number: Case-Specific Approval of Disease Control for Manufacture No. 1096813815 |
> |
- AnaTimmu BioMed won the First Prize of Merck’s Advance Biotech Grant Program(2019/9/20)
- Medical Taiwan 2019 Exhibition(2019/6/27~30)
English 
Chinese